Literature DB >> 7566969

Lymphoid- and myeloid-specific activity of the PU.1 promoter is determined by the combinatorial action of octamer and ets transcription factors.

B Kistler1, P Pfisterer, T Wirth.   

Abstract

The putative oncogene PU.1/Spi-1 is a member of the ets-family of transcription factors normally expressed in a subset of hematopoietic cell types. Here we have characterized the role of the PU.1 promoter region for the cell-type specific expression. The proximal 120 bp are sufficient to mediate a high level of activity specifically in B cells and macrophages. Three important motifs could be identified within this region. Two of them, an ets binding site (EBS) and a variant octamer motif were most important for cell-type-specific promoter activity in B cells and macrophages. An additional Sp1 motif stimulates basal activity of this promoter element. The relative contribution to overall activity of octamer motif and EBS differs in B cells and macrophages. In B cells, both octamer motif and EBS combine to mediate high level activity, whereas in macrophages the EBS predominantly confers promoter activity. Both the Oct1 and Oct2 transcription factors, presumably in combination with a B-cell-restricted coactivator, are responsible for the activity of the variant octamer motif in B cells. Interestingly, the PU.1 transcription factor can functionally interact with the EBS in its own promoter, suggesting a positive feedback regulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7566969

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Direct conversion of human fibroblasts to multilineage blood progenitors.

Authors:  Eva Szabo; Shravanti Rampalli; Ruth M Risueño; Angelique Schnerch; Ryan Mitchell; Aline Fiebig-Comyn; Marilyne Levadoux-Martin; Mickie Bhatia
Journal:  Nature       Date:  2010-11-07       Impact factor: 49.962

2.  Characterization of the mouse myeloid-associated differentiation marker (MYADM) gene: promoter analysis and protein localization.

Authors:  Karin Dannaeus; Marina Bessonova; Jan-Ingvar Jönsson
Journal:  Mol Biol Rep       Date:  2005-09       Impact factor: 2.316

3.  CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells under the control of Oct2.

Authors:  P Pfisterer; H König; J Hess; G Lipowsky; B Haendler; W D Schleuning; T Wirth
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

4.  Potential autoregulation of transcription factor PU.1 by an upstream regulatory element.

Authors:  Yutaka Okuno; Gang Huang; Frank Rosenbauer; Erica K Evans; Hanna S Radomska; Hiromi Iwasaki; Koichi Akashi; Francoise Moreau-Gachelin; Youlin Li; Pu Zhang; Berthold Göttgens; Daniel G Tenen
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

5.  ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.

Authors:  Beatrice U Mueller; Thomas Pabst; José Fos; Vibor Petkovic; Martin F Fey; Norio Asou; Ulrich Buergi; Daniel G Tenen
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

6.  Histone deacetylase 1 activates PU.1 gene transcription through regulating TAF9 deacetylation and transcription factor IID assembly.

Authors:  Wei Jian; Bowen Yan; Suming Huang; Yi Qiu
Journal:  FASEB J       Date:  2017-06-01       Impact factor: 5.191

7.  Graded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate.

Authors:  Stella T Chou; Eugene Khandros; L Charles Bailey; Kim E Nichols; Christopher R Vakoc; Yu Yao; Zan Huang; John D Crispino; Ross C Hardison; Gerd A Blobel; Mitchell J Weiss
Journal:  Blood       Date:  2009-06-02       Impact factor: 22.113

8.  IRF8 regulates B-cell lineage specification, commitment, and differentiation.

Authors:  Hongsheng Wang; Chang Hoon Lee; Chenfeng Qi; Prafullakumar Tailor; Jianxun Feng; Sadia Abbasi; Toru Atsumi; Herbert C Morse
Journal:  Blood       Date:  2008-09-17       Impact factor: 22.113

9.  BOB.1/OBF.1 controls the balance of TH1 and TH2 immune responses.

Authors:  Cornelia Brunner; Anca Sindrilaru; Irute Girkontaite; Klaus-Dieter Fischer; Cord Sunderkötter; Thomas Wirth
Journal:  EMBO J       Date:  2007-06-14       Impact factor: 11.598

10.  Btk expression is controlled by Oct and BOB.1/OBF.1.

Authors:  Cornelia Brunner; Thomas Wirth
Journal:  Nucleic Acids Res       Date:  2006-03-31       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.